2022 BSH指南:慢性淋巴细胞白血病的治疗

2022-03-21 英国血液病学学会 Br J Haematol

2022年3月,英国血液病学学会(BSH)发布了慢性淋巴细胞白血病的治疗指南,本文是对2018年慢性淋巴细胞白血病治疗指南的更新,主要内容涉及治疗前的考虑,一线治疗建议,复发或难治性疾病的管理,BKT

中文标题:

2022 BSH指南:慢性淋巴细胞白血病的治疗

英文标题:

Guideline for the treatment of chronic lymphocytic leukaemia

发布机构:

英国血液病学学会

发布日期:

2022-03-21

简要介绍:

2022年3月,英国血液病学学会(BSH)发布了慢性淋巴细胞白血病的治疗指南,本文是对2018年慢性淋巴细胞白血病治疗指南的更新,主要内容涉及治疗前的考虑,一线治疗建议,复发或难治性疾病的管理,BKTi不耐受者的管理以及疫苗接种和预防指南。

相关资料下载:
[AttachmentFileName(sort=1, fileName=2022 BSH指南:慢性淋巴细胞白血病的治疗.pdf)] GetToolGuiderByIdResponse(projectId=1, id=3748d1c00239024a, title=2022 BSH指南:慢性淋巴细胞白血病的治疗, enTitle=Guideline for the treatment of chronic lymphocytic leukaemia, guiderFrom=Br J Haematol, authorId=0, author=, summary=2022年3月,英国血液病学学会(BSH)发布了慢性淋巴细胞白血病的治疗指南,本文是对2018年慢性淋巴细胞白血病治疗指南的更新,主要内容涉及治疗前的考虑,一线治疗建议,复发或难治性疾病的管理,BKT, cover=https://img.medsci.cn/2022322/1647949929613_1608702.jpg, journalId=0, articlesId=null, associationId=1339, associationName=英国血液病学学会, associationIntro=, copyright=0, guiderPublishedTime=Mon Mar 21 00:00:00 CST 2022, originalUrl=, linkOutUrl=, content=<p><span style="color: #373737;">2022年3月,英国血液病学学会(BSH)发布了慢性淋巴细胞白血病的治疗指南,本文是对2018年慢性淋巴细胞白血病治疗指南的更新,主要内容涉及治疗前的考虑,一线治疗建议,复发或难治性疾病的管理,BKTi不耐受者的管理以及疫苗接种和预防指南。</span></p>, tagList=[TagDto(tagId=4180, tagName=慢性淋巴细胞白血病), TagDto(tagId=117037, tagName=髓系疾病)], categoryList=[CategoryDto(categoryId=21, categoryName=血液科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=0, guiderKeyword=, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=2, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=8176, appHits=137, showAppHits=0, pcHits=464, showPcHits=8039, likes=1, shares=19, comments=4, approvalStatus=1, publishedTime=Wed Mar 23 15:37:00 CST 2022, publishedTimeString=2022-03-21, pcVisible=1, appVisible=1, editorId=0, editor=dajiong, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=3, createdBy=null, createdName=dajiong, createdTime=Tue Mar 22 19:58:40 CST 2022, updatedBy=1608702, updatedName=dajiong, updatedTime=Sat Jan 06 19:20:45 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2022 BSH指南:慢性淋巴细胞白血病的治疗.pdf)])
2022 BSH指南:慢性淋巴细胞白血病的治疗.pdf
下载请点击:
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1220409, encodeId=6be9122040926, content=<a href='/topic/show?id=bde45355068' target=_blank style='color:#2F92EE;'>#慢性淋巴细胞白血病#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53550, encryptionId=bde45355068, topicName=慢性淋巴细胞白血病)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=赛华佗, createdTime=Tue May 17 16:41:09 CST 2022, time=2022-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214789, encodeId=d3c01214e890f, content=实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=427d4785086, createdName=su_yi_fei, createdTime=Tue Apr 26 20:09:32 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1205328, encodeId=659d120532888, content=好好学习!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7d296543951, createdName=ms3000000722483498, createdTime=Wed Mar 23 19:28:53 CST 2022, time=2022-03-23, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1220409, encodeId=6be9122040926, content=<a href='/topic/show?id=bde45355068' target=_blank style='color:#2F92EE;'>#慢性淋巴细胞白血病#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53550, encryptionId=bde45355068, topicName=慢性淋巴细胞白血病)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=赛华佗, createdTime=Tue May 17 16:41:09 CST 2022, time=2022-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214789, encodeId=d3c01214e890f, content=实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=427d4785086, createdName=su_yi_fei, createdTime=Tue Apr 26 20:09:32 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1205328, encodeId=659d120532888, content=好好学习!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7d296543951, createdName=ms3000000722483498, createdTime=Wed Mar 23 19:28:53 CST 2022, time=2022-03-23, status=1, ipAttribution=)]
    2022-04-26 su_yi_fei

    实用

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1220409, encodeId=6be9122040926, content=<a href='/topic/show?id=bde45355068' target=_blank style='color:#2F92EE;'>#慢性淋巴细胞白血病#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53550, encryptionId=bde45355068, topicName=慢性淋巴细胞白血病)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=赛华佗, createdTime=Tue May 17 16:41:09 CST 2022, time=2022-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214789, encodeId=d3c01214e890f, content=实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=427d4785086, createdName=su_yi_fei, createdTime=Tue Apr 26 20:09:32 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1205328, encodeId=659d120532888, content=好好学习!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7d296543951, createdName=ms3000000722483498, createdTime=Wed Mar 23 19:28:53 CST 2022, time=2022-03-23, status=1, ipAttribution=)]
    2022-03-23 ms3000000722483498

    好好学习!

    0